Mortality and mobidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the VALIANT trial

Harvey White, Philip Aylward, Zhen Huang, Anthony Dalby, W Weaver, Stale Barvik, Jose Marin-Neto, Jan Murin, Rolf Nordlander, Wiek van Gilst, Faiez Zannad, John McMurray, Robert Califf, Marc Pfeffer

    Research output: Contribution to journalArticle

    85 Citations (Scopus)
    Original languageEnglish
    Article numberCC
    Pages (from-to)3391-3399
    Number of pages9
    JournalCirculation
    Volume112
    Issue number22
    Publication statusPublished - 2005

    Cite this

    White, H., Aylward, P., Huang, Z., Dalby, A., Weaver, W., Barvik, S., Marin-Neto, J., Murin, J., Nordlander, R., van Gilst, W., Zannad, F., McMurray, J., Califf, R., & Pfeffer, M. (2005). Mortality and mobidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the VALIANT trial. Circulation, 112(22), 3391-3399. [CC].